Programme CORTISONE– Notice of Request for Information Relating to a Draft Statement of Requirement for an Enterprise Master Patient Index and Healthcare Provider Directory

Programme CORTISONE– Notice of Request for Information Relating to a draft Statement of Requirement for an Enterprise Master Patient Index and Healthcare Provider Directory available through the CORTISONE Supplier Portal

This announcement invites interested suppliers to request access to the CORTISONE Supplier Portal to view the draft Statement of Requirement for an Enterprise Master Patient Index and Healthcare Provider Directory for the CORTISONE Programme within the UK Ministry of Defence (MOD). A further announcement will be published inviting suppliers to request access to the draft Statement of Requirement for an Integration Platform and Clinical Portal for the CORTISONE Programme.

Following on from a series of Discovery Days (July to November 2018) and the CORTISONE Industry Day (28 January 2019 at techUK in London), the CORTISONE Programme is issuing a Request for Information (RFI). This RFI invites interested suppliers to read and provide feedback on the draft Statement of Requirement for the Programme’s planned procurement of an Enterprise Master Patient Index and Healthcare Provider Directory. The CORTISONE team intends to provide further details of the procurement itself later in 2019. The Programme team intends to procure the Enterprise Master Patient Index and Healthcare Provider Directory through a suitable framework.

Overview of Enterprise Master Patient Index and Healthcare Provider Directory Requirements

An Enterprise Master Patient Index (EMPI) is required to enable the identification, matching and linking of patient records stored across the multiple IT systems that exist now and, in the future, both in Defence and the NHS. The EMPI will unify legacy systems and new systems, and provide a master demographics source (Single Best Record) for Defence Med IS.

The Healthcare Provider Directory will maintain and publish a number of master data entities including the Defence Medical Services (DMS) Organisation structures [DMS Organisation Directory], the four nation NHS Organisation structures that are needed by DMS for messaging addressing, e.g. ODS codes, [NHS Organisation Directory], the DMS clinicians and other users of information services delivered by CORTISONE [DMS User Directory], and the relationships that exist between Organisation Units and Patients/Users.

How do I get access to the information?

The CORTISONE team intends to make the RFI and the draft Statement of Requirement available through the CORTISONE Supplier Portal, a new online workspace that will enable the Programme to share information with suppliers of relevant products and services in pre-procurement market engagement.

Suppliers are invited to request access to the CORTISONE Supplier Portal by nominating up to two representatives from their company to be granted membership.

The representatives should provide the following information to ISSDev-ASDT-EngageCORTISONE-Gp@mod.gov.uk:

  • Full name of company;
  • Full name(s) of representative(s);
  • Role(s) of the representative(s) within the company;
  • Company email address(es) of representative(s). This email will be associated with their membership of the portal.

Invitations will be sent to the nominated email addresses with a link providing access to the CORTISONE Supplier Portal, along with instructions for finding and responding to the RFI and the draft Statement of Requirement.

Please note that completed RFI questionnaires should be returned to the CORTISONE Team by email to ISSDev-ASDT-EngageCORTISONE-Gp@mod.gov.uk no later than 10:00 GMT on 18 March 2019.

CORTISONE Supplier Portal

The CORTISONE Supplier Portal is a new online workspace that enables the CORTISONE Programme to share information with suppliers of relevant products and services in pre-procurement market engagement. This may include draft Statements of Requirements for different products and services that CORTISONE intends to procure as well as draft design artefacts that provide useful technical details for suppliers interested in the Programme. The portal also provides information about the context and status of the CORTISONE Programme in the CORTISONE Overview pages.

Significant additions to the content published on the CORTISONE Supplier Portal will be announced on Defence Contracts Online first. Suppliers will be given the opportunity to request access to the CORTISONE Supplier Portal on a rolling basis. Any queries about access to the CORTISONE Supplier Portal should be directed to ISSDev-ASDT-EngageCORTISONE-Gp@mod.gov.uk.

Responding to this announcement is voluntary and does not start the official procurement process for the CORTISONE requirement. Participation in the CORTISONE Supplier Portal does not guarantee, or jeopardise, your inclusion in a future procurement exercise. It should be noted that all information released in relation to the CORTISONE Supplier Portal is released on a without commitment basis, is subject to change and may not form part of any future procurement process.

No down-selection will take place as a consequence of any responses or interactions relating to the CORTISONE Supplier Portal unless stated otherwise. Additionally, no information provided in response to this announcement or in relation to the CORTISONE Supplier Portal will be used in any way for the purpose of evaluating suppliers or their products in any future procurement process.

What is Programme CORTISONE?

The aim of Programme CORTISONE is to deliver an integrated ecosystem of medical information services to the Defence Medical Services (DMS). Its vision is to deliver ‘a sustainable, integrated, cohesive and enduring information capability that will fully and effectively support the delivery of evidence-based medical and dental health and healthcare outputs, to achieve the Aim of the Defence Medical Services’ – which is to Promote, Protect and Restore the health of the Defence population in order to maximise their fitness for role, while maintaining an occupational focus and an operational edge.

A multi-million-pound programme, with global reach and operations equivalent in size to two large CCGs (Clinical Commissioning Groups) and a Community Trust, CORTISONE looks to procure a full suite of healthcare software from multiple healthcare product/service suppliers, together with develop and deliver services. It is anticipated that elements of the ecosystem will be re-competed on a regular basis to ensure the best solutions are being delivered to users, giving an ongoing opportunity for market players to get involved with the ecosystem on a long-term basis.

The MOD is looking for a range of companies to engage with the programme, delivering a full suite of healthcare software to meet use-cases and patient-journey-defined functional requirements. With the modular nature of the procurement allowing innovation, all suppliers are encouraged to take a leading role in delivery of functionality.

The CORTISONE programme has been engaging with suppliers through Industry Days on 17 May 2018 and 28 January 2019 and through a series of Discovery Days, where it has invited potential suppliers to present information on services and demonstrate products to relevant technical and business staff from the CORTISONE programme.  Previous Discovery Days have addressed:

  • Primary Medical Care (Discovery Day 1, 30 July 2018)
  • Dental Healthcare (Discovery Day 2, 31 July 2018)
  • Integration Platform (Discovery Day 3, 1 and 2 October 2018)
  • Enterprise Master Patient Index (Discovery Day 4, 23 and 24 October 2018)
  • Document Management (Discovery Day 5, 12 and 13 November 2018)

CORTISONE is also looking to the future and will exploit innovation to align with NHS strategy, virtualise healthcare and integrate with services across the healthcare sector. This might include telemedicine, patient record integration with the NHS and other patient databases, patient condition tracking etc.